323 related articles for article (PubMed ID: 29782524)
1. Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
Pavanello S; Varesco L; Gismondi V; Bruzzi P; Bolognesi C
PLoS One; 2018; 13(5):e0197522. PubMed ID: 29782524
[TBL] [Abstract][Full Text] [Related]
2. Telomere Length Is Predictive of Breast Cancer Risk in
Thorvaldsdottir B; Aradottir M; Stefansson OA; Bodvarsdottir SK; Eyfjörd JE
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1248-1254. PubMed ID: 28235830
[No Abstract] [Full Text] [Related]
3. Telomere length shows no association with BRCA1 and BRCA2 mutation status.
Killick E; Tymrakiewicz M; Cieza-Borrella C; Smith P; Thompson DJ; Pooley KA; Easton DF; Bancroft E; Page E; Leongamornlert D; ; Kote-Jarai Z; Eeles RA
PLoS One; 2014; 9(1):e86659. PubMed ID: 24489760
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status.
Pooley KA; McGuffog L; Barrowdale D; Frost D; Ellis SD; Fineberg E; Platte R; Izatt L; Adlard J; Bardwell J; Brewer C; Cole T; Cook J; Davidson R; Donaldson A; Dorkins H; Douglas F; Eason J; Houghton C; Kennedy MJ; McCann E; Miedzybrodzka Z; Murray A; Porteous ME; Rogers MT; Side LE; Tischkowitz M; Walker L; Hodgson S; Eccles DM; Morrison PJ; Evans DG; Eeles RA; Antoniou AC; Easton DF; Dunning AM;
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1018-24. PubMed ID: 24642354
[TBL] [Abstract][Full Text] [Related]
5. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
[TBL] [Abstract][Full Text] [Related]
6. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
[TBL] [Abstract][Full Text] [Related]
7. Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
Pellatt AJ; Wolff RK; Torres-Mejia G; John EM; Herrick JS; Lundgreen A; Baumgartner KB; Giuliano AR; Hines LM; Fejerman L; Cawthon R; Slattery ML
Genes Chromosomes Cancer; 2013 Jul; 52(7):595-609. PubMed ID: 23629941
[TBL] [Abstract][Full Text] [Related]
8. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.
Martinez-Delgado B; Yanowsky K; Inglada-Perez L; de la Hoya M; Caldes T; Vega A; Blanco A; Martin T; Gonzalez-Sarmiento R; Blasco M; Robledo M; Urioste M; Song H; Pharoah P; Benitez J
J Med Genet; 2012 May; 49(5):341-4. PubMed ID: 22493152
[TBL] [Abstract][Full Text] [Related]
9. Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients.
Benitez-Buelga C; Sanchez-Barroso L; Gallardo M; Apellániz-Ruiz M; Inglada-Pérez L; Yanowski K; Carrillo J; Garcia-Estevez L; Calvo I; Perona R; Urioste M; Osorio A; Blasco MA; Rodriguez-Antona C; Benitez J
Breast Cancer Res Treat; 2015 Jan; 149(2):385-94. PubMed ID: 25528024
[TBL] [Abstract][Full Text] [Related]
10. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.
Martinez-Delgado B; Gallardo M; Tanic M; Yanowsky K; Inglada-Perez L; Barroso A; Rodriguez-Pinilla M; Cañamero M; Blasco MA; Benitez J
Breast Cancer Res Treat; 2013 Sep; 141(2):231-42. PubMed ID: 24036693
[TBL] [Abstract][Full Text] [Related]
11. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
12. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
13. Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Welsh JL; Hoskin TL; Day CN; Thomas AS; Cogswell JA; Couch FJ; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):3067-3072. PubMed ID: 28766224
[TBL] [Abstract][Full Text] [Related]
14. Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
Shah PD; Patil S; Dickler MN; Offit K; Hudis CA; Robson ME
Cancer; 2016 Apr; 122(8):1178-84. PubMed ID: 26859126
[TBL] [Abstract][Full Text] [Related]
15. Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.
Kroupa M; Rachakonda S; Vymetalkova V; Tomasova K; Liska V; Vodenkova S; Cumova A; Rossnerova A; Vodickova L; Hemminki K; Soucek P; Kumar R; Vodicka P
Mutagenesis; 2020 Dec; 35(6):491-497. PubMed ID: 33367858
[TBL] [Abstract][Full Text] [Related]
16. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary hypothesis of telomere length in primary breast cancer and brain tumour patients: a tracer for genomic-tumour heterogeneity and instability.
Mehdipour P; Kheirollahi M; Mehrazin M; Kamalian N; Atri M
Cell Biol Int; 2011 Sep; 35(9):915-25. PubMed ID: 21385157
[TBL] [Abstract][Full Text] [Related]
18. Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
Zeng H; Wu HC; Wang Q; Yang HI; Chen CJ; Santella RM; Shen J
Anticancer Res; 2017 Feb; 37(2):637-644. PubMed ID: 28179311
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of telomere genes in BRCA1/2-negative breast cancer families with very short telomeres.
Yanowsky K; Barroso A; Osorio A; Urioste M; Benitez J; Martinez-Delgado B
Breast Cancer Res Treat; 2012 Aug; 134(3):1337-43. PubMed ID: 22752289
[TBL] [Abstract][Full Text] [Related]
20. Limited family structure and BRCA gene mutation status in single cases of breast cancer.
Weitzel JN; Lagos VI; Cullinane CA; Gambol PJ; Culver JO; Blazer KR; Palomares MR; Lowstuter KJ; MacDonald DJ
JAMA; 2007 Jun; 297(23):2587-95. PubMed ID: 17579227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
